Chmiela Tomasz M, Benitez Edmar O, Ortiz-Cruz Gabriela, Strongosky Audrey J, Thatikala Abhilash, Nalleballe Krishna, Ayala Ernesto, Middlebrooks Erik H, Wszolek Zbigniew K
Department of Neurology, Mayo Clinic Florida, Jacksonville, USA; Department of Neurology, Faculty of Medical Sciences, Medical University of Silesia, Katowice, Poland.
Neuroscience Center, Angeles Pedregal Hospital, Mexico City, Mexico.
Parkinsonism Relat Disord. 2025 Aug;137:107906. doi: 10.1016/j.parkreldis.2025.107906. Epub 2025 Jun 6.
Colony-stimulating factor-1 receptor (CSF1R)-related disorder (CSF1R-RD) is a rapidly progressive neurodegenerative disease that typically presents with a frontotemporal dementia-like phenotype with motor impairment, including pyramidal and extrapyramidal signs. Recognition of CSF1R-RD has increased with the availability of genetic testing, but most published cases are from Asia, Europe, and North America. Little is known about the prevalence of CSF1R-RD in Hispanic populations.
We collected cases of patients of Hispanic ethnicity with CSF1R-RD diagnosed at Mayo Clinic or centers in Mexico. Data collected included country of origin, ethnicity, sex, age, family history, clinical symptoms, age of symptom onset, and results of neuroimaging studies.
We identified a mutation in the CSF1R gene in 7 patients from 6 unrelated families, including a previously unreported variant, c.670T > A (p.Cys224Ser). Two patients resided in Mexico and 5 lived in the US (3 of Mexican ancestry, 2 of Puerto Rican ancestry). Five families had multiple cases of early dementia or movement disorders. In 4 patients, initial symptoms included behavioral and cognitive changes; 1 developed motor symptoms in the early stages. Mean (SD) age of onset was 28.6 (12.4) years. Three patients have progressed rapidly, requiring total care, 2 are moderately affected and still largely independent, and 2 remain asymptomatic. One patient underwent bone marrow transplantation which slowed symptom progression; 1 asymptomatic patient chose corticosteroid prophylaxis.
We highlight the presence of CSF1R-RD in Hispanic populations. As disease-modifying therapy for CSF1R-RD is available, there is a need to identify CSF1R-RD to facilitate treatment.
集落刺激因子1受体(CSF1R)相关疾病(CSF1R-RD)是一种快速进展的神经退行性疾病,通常表现为具有运动障碍的额颞叶痴呆样表型,包括锥体束和锥体外系体征。随着基因检测的出现,对CSF1R-RD的认识有所增加,但大多数已发表的病例来自亚洲、欧洲和北美。关于西班牙裔人群中CSF1R-RD的患病率知之甚少。
我们收集了在梅奥诊所或墨西哥各中心诊断为CSF1R-RD的西班牙裔患者病例。收集的数据包括原籍国、种族、性别、年龄、家族史、临床症状、症状发作年龄以及神经影像学研究结果。
我们在来自6个无关家族的7名患者中发现了CSF1R基因的突变,包括一个先前未报告的变体c.670T>A(p.Cys224Ser)。2名患者居住在墨西哥,5名居住在美国(3名有墨西哥血统,2名有波多黎各血统)。5个家族有多例早期痴呆或运动障碍病例。4名患者的初始症状包括行为和认知改变;1名患者在疾病早期出现运动症状。平均(标准差)发病年龄为28.6(12.4)岁。3名患者病情进展迅速,需要全面护理,2名患者受中度影响,仍基本独立,2名患者仍无症状。1名患者接受了骨髓移植,症状进展减缓;1名无症状患者选择了皮质类固醇预防治疗。
我们强调西班牙裔人群中存在CSF1R-RD。由于已有针对CSF1R-RD的疾病修饰疗法,因此需要识别CSF1R-RD以便于治疗。